hfa_icos_bcr_abl

Lyon 2020 HFA-ICOS baseline cardiovascular risk before second- or third-generation multi-targeted kinase inhibitors for CML targeting BCR-ABL.

Lyon 2020 HFA-ICOS baseline cardiovascular risk before second- or third-generation multi-targeted kinase inhibitors for CML targeting BCR-ABL. Class is very_high, high, medium, or low from published very-high and high factors plus Medium 1/2 points (0–1 low, 2–4 medium, ≥5 high). Caller assigns the 10-year CVD >20% threshold; magent does not compute that score. Not a medical device or treatment order.

UNRATEDListed

Overview

Grade?

UNRATED

0 of 30 paid calls toward a letter

Price

$0.005 per call

Paid calls

none yet

delivery unknown until someone pays

More info

Seller?

0x836be278…1bc19ee2

URL

https://api.magentlab.com/api/calc/hfa_icos_bcr_abl

Seen

first 29 days ago · last 16 hr ago

26 free handshakes

Payment

Pays through

x402

Offered on?

Base USDC

Listed on?

Base

Paid calls

No paid calls yet.

Delivery is unknown until someone pays. A handshake only shows it asks for payment.

Verify it yourselfnpx teppi-check https://api.magentlab.com/api/calc/hfa_icos_bcr_ablcurl -s https://api.teppi.xyz/v1/trust/cap_01M1RD9JSAQTR9PSYA55C60V7K